Source: MarketScreener

Achillion: Achillion Pharmaceuticals : Ahold Delhaize share buyback update July 28, 2020

(marketscreener.com) Zaandam, the Netherlands, July 28, 2020 - Ahold Delhaize has repurchased 250,000 of Ahold Delhaize common shares in the period from July 20, 2020 up to and including July 24, 2020. The shares were repurchased at an average price of €25.16 per share for a total consideration of € 6.29 million. These repurchases were made...https://www.marketscreener.com/ACHILLION-PHARMACEUTICALS-35614/news/Achillion-Pharmaceuticals-Ahold-Delhaize-share-buyback-update-July-28-2020-31001292/?utm_medium=RSS&utm_content=20200728

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joseph Truitt's photo - President & CEO of Achillion Pharmaceuticals Inc

President & CEO

Joseph Truitt

CEO Approval Rating

87/100

Read more